Tegrital CR 300 mg Divitabs
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Tegrital CR 300 mg Divitabs is a controlled-release (CR) tablet containing carbamazepine, an anti-epileptic medicine. Its labelling describes it for treating epilepsy and preventing seizures, and it is also prescribed for trigeminal neuralgia (a painful condition of the face, head, and neck) and for diabetes-related nerve pain (diabetic neuropathy). The controlled-release formulation is described as giving slow but prolonged effects. It should be taken as prescribed by the doctor, and missing a single dose may cause seizures to rebound.
Product Information
The following description reflects information associated with carbamazepine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Epilepsy / seizures — described as controlling focal (partial) and generalised tonic-clonic seizures
- Trigeminal neuralgia — described as reducing extreme facial nerve pain
- Bipolar disorder — described as controlling and stabilising mood and preventing manic episodes
- Neuropathic pain — described as prescribed for nerve pain conditions such as diabetic neuropathy; also used for migraine
Described Dosage & Administration
- Prescribed by the doctor depending on the severity of the condition and symptoms; the dose may be increased or decreased as the condition changes
- A consistent schedule should be maintained; a dose should not be skipped or doubled, as this can cause severe side effects or rebound seizures
- In case of overdose, immediate medical attention should be sought
Described Side Effects
The medicine is described as having no harmful side effects. Minimal side effects that may occur include:
- Nausea
- Vomiting
- Dizziness
- Constipation
These are described as not persisting and subsiding once the body is accustomed to the medicine. A doctor should be contacted if they last long.
Precautions
- The doctor should always be asked before stopping the medicine, as stopping can worsen the condition
- Alcohol is described as a strict no, as it can react with the medicine causing drowsiness or dizziness
- Lactating mothers or pregnant women should consult a doctor before taking it, as it can lead to birth defects
- Anyone with existing liver or kidney issues should talk to the doctor
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains carbamazepine and is used for epilepsy and seizure prevention, trigeminal neuralgia, bipolar disorder, and neuropathic pain such as diabetic neuropathy. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken daily on a consistent schedule as prescribed by the doctor. Missing a single dose may cause seizures to rebound, and the medicine should not be stopped without asking the doctor.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.